0001213900-20-036548.txt : 20201112 0001213900-20-036548.hdr.sgml : 20201112 20201112161648 ACCESSION NUMBER: 0001213900-20-036548 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UAS Drone Corp. CENTRAL INDEX KEY: 0001638911 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] IRS NUMBER: 473052410 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-237927 FILM NUMBER: 201306914 BUSINESS ADDRESS: STREET 1: 1 ETGAR ST. STREET 2: 1ST FLOOR CITY: TIRAT CARMEL STATE: L3 ZIP: 3903212 BUSINESS PHONE: 011-972-4-8124101 MAIL ADDRESS: STREET 1: 1 ETGAR ST. STREET 2: 1ST FLOOR CITY: TIRAT CARMEL STATE: L3 ZIP: 3903212 424B3 1 ea129732-424b3_uasdrone.htm PROSPECTUS SUPPLEMENT

PROSPECTUS SUPPLEMENT NO. 2

FILED PURSUANT TO RULE 424(b)(3)

TO PROSPECTUS DATED JUNE 19, 2020

REGISTRATION STATEMENT NO.

333-237927

 

 

UAS DRONE CORP.

 

63,856 SHARES OF COMMON STOCK BEING SOLD AT $0.374 PER SHARE PURSUANT TO THE PRIMARY OFFERING AND RESALE OF 18,200,592 SHARES OF COMMON STOCK OFFERED BY SELLING STOCKHOLDERS

 

This Prospectus Supplement No. 2 supplements our Prospectus dated June 19, 2020 (the “Prospectus”) that forms a part of our Registration Statement on Form S-1 (Securities and Exchange Commission File No. 333-237927).  This Prospectus Supplement No. 2 is being filed to update and supplement certain information contained in the Prospectus with the information contained in our Quarterly Report on Form 10-Q for the period ended September 30, 2020, filed with the Securities and Exchange Commission on November 12, 2020 (the “Quarterly Report”).  Accordingly, we have attached the Quarterly Report to this Prospectus Supplement.  

 

This Prospectus Supplement No. 2 should be read in conjunction with the Prospectus and all prior supplements thereto, which are required to be delivered with this Prospectus Supplement.  If there is any inconsistency between the information in the Prospectus, any prior supplements thereto, and this Prospectus Supplement, you should rely on the information in this Prospectus Supplement.

 

These securities involve a high degree of risk.  You should carefully consider the risks identified under the caption “Risk Factors” beginning on Page 4 of the Prospectus and those under similar headings in any amendment or supplements to the Prospectus.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of any of these securities or passed upon the adequacy or accuracy of the Prospectus or this Prospectus Supplement.  Any representation to the contrary is a criminal offense.

 

The date of this Prospectus Supplement is November 12, 2020.